Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 1;13(6):e0197540.
doi: 10.1371/journal.pone.0197540. eCollection 2018.

Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis

Affiliations
Free PMC article

Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis

Khaled Mohamed Hosny et al. PLoS One. .
Free PMC article

Abstract

There are many challenges facing the use of alendronate sodium for the treatment of osteoporosis such as low bioavailability of 0.6% and oesophageal ulceration with bleeding. Due to the aforementioned limitation, the main objective of this research is to utilize a statistical experimental design in the formulation and optimization of alendronate in the form of controlled release biodegradable intramuscular in-situ gel. A Box-Behnken experimental design employing Statgraphics® software was used to develop an optimized in-situ gel formulation and to estimate the effects of Poly-DL-lactide-coglycolide as a primary polymer, the copolymer polycaprolactone, and lipid surfactant capryol 90. Every system was evaluated for gellation character, and in vitro release. As a novel technique for evaluation of the in-situ gel, in-vivo biodegradability rate was estimated in rats. Pharmacokinetic parameters were assessed in rabbits. The results indicated a significant effect of the copolymer and lipid surfactant on initial burst, and a significant effect of the primary and copolymer on drug percentage released. The optimum formulation showed a 5% initial burst, an in-vivo biodegradability rate estimated at 8% every seven days in rats, and the pharmacokinetic evaluation revealed that alendronate sodium mean residence time extended to 102 days in rabbits. In conclusion, the optimum biodegradable intramuscular in-situ gel formulations is a promising approach for providing higher bioavailability, extended release for more than three months, with elimination of esophageal side effects.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. In-vitro release of alendronate sodium from different formulations.
Fig 2
Fig 2
A, and D = Standardized Pareto charts for the effect of the studied variables on Y1 and Y2, respectively. B and E = Main effect plots for the effect of the studied variables on Y1 and Y2, respectively. C and F = Contour plots showing the relationship between various levels of the two significantly effects variables to attain fixed values of Y1 and Y2, respectively.
Fig 3
Fig 3. Relation between percent weight of implant remain intact inside the rat muscle and time intervals.

Similar articles

Cited by

References

    1. Hosny KM, Osama A, Al-abdaly R. Enteric-coated alendronate sodium nanoliposomes: a novel formulations to overcome barriers for the treatment of osteoporosis. Expert Opinion on Drug Delivery 2013;10(6):741–6 doi: 10.1517/17425247.2013.799136 - DOI - PubMed
    1. Bone H G, Hosking D, Devogelaer J, Tucci J R, Emkey R D, Tonino R P, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. New England Journal of Medicine, 2004;350:1189–99. doi: 10.1056/NEJMoa030897 - DOI - PubMed
    1. Schnitzer T, Bone H G, Crepaldi G, Adami S, McClung M, Kiel D, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clinical and Experimental Research, 2000:12;1–12. - PubMed
    1. Hosny KM. Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability. PLOS ONE 2016;11(5):e0154926 doi: 10.1371/journal.pone.0154926 - DOI - PMC - PubMed
    1. Peters ML, Leonard M, Licata AA. Role of Alendronate and Risedronate in Preventing and Treating Osteoporosis. Cleve Clin J Med 2001;68:945–51. - PubMed

Publication types

MeSH terms

Grants and funding

This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-002-166-1438).